Cellectar’s technology, based on research done by a University of Wisconsin-Madison team led by radiology professor Jamey Weichert, uses fat-like molecules to deliver radioisotopes that can either destroy malignant cells or enable imaging equipment to locate them.
Office of Strategic Communication